Immunocore Limited
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$6.2M
Doctors Paid
914
Transactions
2,327
2024 Total
$2.0M
Payment Breakdown by Category
Research$4.1M (66.2%)
Consulting$1.0M (16.2%)
Travel$80,391 (1.3%)
Food & Beverage$46,329 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.1M | 700 | 66.2% |
| Consulting Fee | $1.0M | 178 | 16.2% |
| Honoraria | $931,969 | 75 | 14.9% |
| Travel and Lodging | $80,391 | 156 | 1.3% |
| Food and Beverage | $46,329 | 1,210 | 0.7% |
| Long term medical supply or device loan | $21,548 | 1 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $17,050 | 6 | 0.3% |
| Education | $30.00 | 1 | 0.0% |
Payments by Type
Research
$4.1M
700 transactions
General
$2.1M
1,627 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Phase I/II, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 using the Intra-patient Escalation Dosing Regimen in Patients with Advanced Uveal Melanoma | $1.2M | 1 | 88 |
| A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared with Investigators Choice in HLA-A0201 Positive Patients with Previously Untreated Advanced Uveal Melanoma | $944,811 | 0 | 83 |
| A Phase Ib/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 in Combination with Durvalumab (MEDI4736) or Tremelimumab or the Combination of Durvalumab and Tremelimumab Compared to IMCgp100 Alone in Patients with Advanced Melanoma | $703,935 | 1 | 274 |
| Randomized Phase 2/3 Study of Tebentafusp Monotherapy or with Pembrolizumab Versus Chemotherapy in HLA-A*02:01-positive Patients with Previously Treated Metastatic Cutaneous Melanoma (TEBE-CM) | $619,013 | 0 | 186 |
| A study to identify participants who may qualify for treatment with investigational molecules developed by, or in conjunction with, Immunocore | $386,260 | 0 | 7 |
| A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared with Investigators Choice in HLA-A*0201 Positive Patients with Previously Untreated Advanced Uveal Melanoma | $125,845 | 0 | 61 |
| Phase II Open-label, Multi-center Study of Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma (mUM) with Integrated Circulating Tumor DNA (ctDNA) Biomaker (TARGET-tebe) | $117,491 | 0 | 1 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Medical Oncology | $981,469 | 68 | $14,433 |
| Emergency Medicine | $745,463 | 2 | $372,732 |
| Hematology & Oncology | $122,847 | 226 | $543.57 |
| Internal Medicine | $64,677 | 96 | $673.72 |
| Student in an Organized Health Care Education/Training Program | $64,255 | 31 | $2,073 |
| Hospice and Palliative Medicine | $24,605 | 4 | $6,151 |
| Gynecologic Oncology | $20,579 | 9 | $2,287 |
| Ophthalmology | $16,747 | 43 | $389.48 |
| Nurse Practitioner | $15,416 | 72 | $214.12 |
| Physician Assistant | $7,991 | 45 | $177.58 |
| Family | $7,782 | 98 | $79.41 |
| Obstetrics & Gynecology | $5,769 | 2 | $2,885 |
| Medical | $4,609 | 23 | $200.38 |
| Acute Care | $3,372 | 20 | $168.60 |
| Pain Medicine | $3,200 | 1 | $3,200 |
| Gastroenterology | $2,400 | 1 | $2,400 |
| Adult Health | $1,584 | 44 | $36.01 |
| Specialist | $966.28 | 20 | $48.31 |
| Hematology | $928.17 | 18 | $51.57 |
| Radiation Oncology | $678.83 | 17 | $39.93 |
| Registered Nurse | $581.77 | 10 | $58.18 |
| Gerontology | $308.96 | 11 | $28.09 |
| Uveitis and Ocular Inflammatory Disease | $216.96 | 1 | $216.96 |
| General Acute Care Hospital | $173.66 | 1 | $173.66 |
| Retina Specialist | $157.20 | 3 | $52.40 |
| Hospitalist | $133.38 | 3 | $44.46 |
| Surgical Oncology | $125.25 | 2 | $62.63 |
| Pediatrics, Critical Care | $124.95 | 1 | $124.95 |
| Surgical | $118.04 | 2 | $59.02 |
| General Practice | $117.81 | 1 | $117.81 |
| MOHS-Micrographic Surgery | $116.12 | 1 | $116.12 |
| Medical-Surgical | $108.41 | 1 | $108.41 |
| Neuroscience | $103.34 | 2 | $51.67 |
| Family Medicine | $98.74 | 4 | $24.69 |
| Optometrist | $76.15 | 3 | $25.38 |
| Oncology | $69.75 | 3 | $23.25 |
| Primary Care | $68.20 | 3 | $22.73 |
| Clinical Genetics (M.D.) | $61.98 | 1 | $61.98 |
| Military Health Care Provider | $54.42 | 1 | $54.42 |
| Body Imaging | $53.61 | 1 | $53.61 |
| Pediatrics | $44.94 | 2 | $22.47 |
| Psychiatric/Mental Health, Adult | $34.55 | 1 | $34.55 |
| Infectious Disease | $34.04 | 1 | $34.04 |
| Neurology | $30.72 | 2 | $15.36 |
| Emergency Medical Services | $29.42 | 1 | $29.42 |
| Otolaryngology | $26.94 | 1 | $26.94 |
| Surgery | $24.62 | 1 | $24.62 |
| Clinical Nurse Specialist | $24.13 | 1 | $24.13 |
| Physical Medicine & Rehabilitation | $24.11 | 1 | $24.11 |
| Diagnostic Radiology | $23.74 | 1 | $23.74 |
| Neonatal, Critical Care | $23.53 | 1 | $23.53 |
| Psychiatric/Mental Health | $22.94 | 1 | $22.94 |
| Nurse Anesthetist, Certified Registered | $21.16 | 1 | $21.16 |
| Women's Health | $17.69 | 1 | $17.69 |
| Chiropractor | $17.46 | 1 | $17.46 |
| Rheumatology | $15.77 | 1 | $15.77 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Roy Herbst, M.d., Phd, M.D., PHD | Medical Oncology | Houston, TX | $954,603 | $0 |
| Dr. Sushama Scalera, Md, MD | Emergency Medicine | Salem, MA | $745,445 | $0 |
| Dr. Marlana Orloff, Md, MD | Student in an Organized Health Care Education/Training Program | Philadelphia, PA | $32,217 | $0 |
| Omid Hamid, M.d, M.D | Hematology & Oncology | Santa Monica, CA | $29,688 | $0 |
| Dr. Yana Najjar, M.d, M.D | Student in an Organized Health Care Education/Training Program | Washington, DC | $27,405 | $0 |
| Dr. Katherine Wang, Md, Phd, MD, PHD | Hospice and Palliative Medicine | Dallas, TX | $24,221 | $0 |
| Dr. Richard Carvajal, M.d, M.D | Hematology & Oncology | New York, NY | $13,903 | $0 |
| Sajeve Thomas, Md, MD | Hematology & Oncology | Orlando, FL | $12,972 | $0 |
| Dr. Ryan Weight, D.o, D.O | Hematology & Oncology | Aurora, CO | $12,374 | $0 |
| Dr. Inderjit Mehmi, M.d, M.D | Internal Medicine | Los Angeles, CA | $11,094 | $0 |
| Diwakar Davar | Hematology & Oncology | Pittsburgh, PA | $9,243 | $0 |
| Nikhil Khushalani, Md Mbbs, MD MBBS | Medical Oncology | Buffalo, NY | $8,991 | $0 |
| Dr. Geoffrey Gibney, Md, MD | Internal Medicine | Washington, DC | $8,192 | $0 |
| Justin Moser, M.d, M.D | Internal Medicine | Scottsdale, AZ | $7,750 | $0 |
| Lisa Kottschade, R.n., Np, R.N., NP | Nurse Practitioner | Rochester, MN | $6,818 | $0 |
| Siwen Hu-Lieskovan, Md, Phd, MD, PHD | Internal Medicine | Los Angeles, CA | $5,539 | $0 |
| Dr. Frank Hodi, Md, MD | Medical Oncology | Boston, MA | $5,200 | $0 |
| Aaron Mansfield, Md, MD | Internal Medicine | Rochester, MN | $5,000 | $0 |
| Charu Aggarwal, Md, Mph, MD, MPH | Hematology & Oncology | Philadelphia, PA | $4,800 | $0 |
| Robert Coleman, M.d, M.D | Gynecologic Oncology | Houston, TX | $4,485 | $0 |
| Bently Doonan, M.d, M.D | Hematology & Oncology | Jacksonville, FL | $4,066 | $0 |
| Krista Rubin, Np, NP | Nurse Practitioner | Boston, MA | $4,013 | $0 |
| Priyankkumar Patel, Md, MD | Internal Medicine | Urbana, IL | $3,918 | $0 |
| Grace Cherry, Np, NP | Hematology & Oncology | Los Angeles, CA | $3,900 | $0 |
| Erin Shoates, Msn, Fnp, MSN, FNP | Family | Nashville, TN | $3,812 | $0 |
About Immunocore Limited
Immunocore Limited has made $6.2M in payments to 914 healthcare providers, recorded across 2,327 transactions in the CMS Open Payments database. In 2024, the company paid $2.0M. The top product by payment volume is KIMMTRAK ($4.4M).
Payments were distributed across 56 medical specialties. The top specialty by payment amount is Medical Oncology ($981,469 to 68 doctors).
Payment categories include: Food & Beverage ($46,329), Consulting ($1.0M), Research ($4.1M), Travel & Lodging ($80,391).
Immunocore Limited is associated with 1 products in the CMS Open Payments database.